The authorized generic, Insulin Lispro, will have a list price 50 percent lower than Humalog’s current list price of about $275 per vial.
Insulin Lispro will sell for $137.35 for a single vial. A five-pack of the insulin pens will be $265.20.
Eli Lilly and other drug companies have come under increased pressure from lawmakers and the public to reduce the cost of prescription drugs in the U.S. Lawmakers have specifically targeted the skyrocketing price of insulin.
More articles on pharmacy:
How hospitals can better align the pharmacy to achieve its strategic goals
Google sister-company Verily partners with big pharma for clinical trials
Merck’s Keytruda fails late-stage trial as standalone treatment for breast cancer
